Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!
Market Sentiment & Strategy
C-suite optimism for 2025 resurfaces; leaders are rotating assets to fund growth moves in healthcare, energy, and consumer sectors
Volatile tariffs and uneven valuations are pushing buyers to sharpen scenario plans and pursue cross-border targets early
Advisors stress adaptability – firms that iterate strategy and seize dislocations are already locking in attractive multiples
Deal Execution & Best Practices
Elite teams prioritise calm, cross-functional collaboration under pressure, converting complexity into speed
Earn-outs and contingent value rights resurface as risk-sharing devices in uncertain macro conditions
Owners focused on scalable, sustainable fundamentals command buyer trust and shorten time to close
HR & Culture
Post-merger value hinges on rigorous HR integration: clear talent mapping, culture alignment, and rapid leadership deployment
Reputation-building through awards and thought leadership is becoming a pre-sale prerequisite to attract premium buyers
Human-centric change management – transparency, empowerment, and continuous communication cuts integration risk and attrition
Financial & Tax Structuring
Tax architecture and working-capital design are top of mind; missteps here erode synergy capture in year one
Data-center deal values remain buoyant as power scarcity commands premiums; software multiples continue to normalize
Global tariff shifts are redefining life-sciences and consumer-retail target lists, favouring near-shore supply footprints
Technology & Integration
AI-enabled deal tools are moving from pilots to production, compressing diligence timelines and sharpening synergy sizing
Space-economy and dual-use tech assets draw fresh investor attention as governments co-fund scale-up pathways
Distressed HealthTech players increasingly view strategic sales at Series A as a viable continuum rather than a failure
Legal & Governance
Quality legal work – not document volume, drives deal certainty; early integration of IT diligence prevents post-close surprises
Life-sciences buyers are embedding compliance analytics into the term-sheet stage to flag regulatory landmines sooner
Want see the posts voices behind this summary?
This week’s roundup (CW 19/ 20) brings you the Best of LinkedIn on M&A:
→ 63 handpicked posts that cut through the noise
→ 48 fresh voices worth following
→ 1 deep dive you don’t want to miss